Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS107 in adults with moderate to severe atopic dermatitis
2019-000932-25Phase 2Terminated
- Sponsor
- DS Biopharma
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing DS107 with Placebo (2 arms). Primary endpoint: vIGA-AD response at Week 16. Started Jul 2019; status: terminated.
02
Drugs
DS107E
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2019-000932-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000932-25.